{"id":1368,"createDateTime":"2026-08-12T04:12:40.276Z","archiveDateTime":"2027-12-31T00:00:00.000Z","name":"Osteoporotic Fracture vs Atypical Femoral Fracture (AFF)","image":"e47038a006cf6a26f6fcc26839a6a41a501306708d30a1df05682b1b","imageThumbnail":"365e97ca3567b7d1accf0e2f7a837e17c9f3e7b999384095779d33c8","about":"The risk of AFF is an over-emphasised concern about ARDs. This activity reviews the evidence on the real risk of AFF in patients treated with ARDs for osteoporosis and provides practical tips for counselling patients.  \n\nThis activity comprises a short educational video, followed by a reflective activity. Participants must complete both components to qualify for 30 minutes of Reviewing Performance (RP) Hours. \n\n# Learning Outcomes\n1. Outline the risks and clinical significance of atypical femoral fracture in osteoporosis care.\n2. Critically reflect on recent interactions with patients concerned about AFF and osteoporosis treatment.\n3. Apply evidence-based approaches to managing and communicating AFF risk.\n\n# Provider\nThe Provider of this activity is [Praxhub](https://app.praxhub.com/orgs/1). Praxhub is an accredited Major Provider under the RACGP CPD Program. For any questions regarding this activity please contact support@praxhub.com. ","type":"video","summaryViewCount":49,"startDateTime":null,"durationSecs":370,"organisation":{"id":101,"name":"Arrotex","logoImage":"343d2282723763f021df947917df828894bcf90cd0942a7b794bdcd8","logoImageThumbnail":"4cb9c205c6d9ce99135b8445d977a6b5da5a4f07cbd1b9811fbd93f2","industry":"Pharmaceutical"},"provider":{"id":1,"name":"Praxhub","logoImage":"7d8c82e84cfeb7556fa842c1980c93b8144ab0959b0630c17e557baf","logoImageThumbnail":"78ba1e568155afb45aa67fc6f7337c076b0a1aa9182ceb80ac9b1095","industry":"Health Technology"},"commentCount":0,"likeCount":1,"presenters":[{"id":59011,"specialty":{"id":55,"name":"Endocrinology"},"name":"Prof Peter Ebeling","title":null,"profileImage":"130014b42b62e293b3198b082e23b913e49ce03d6287f0d721a2b15a","profileImageThumbnail":"ea7f67280acb2346d48aac22862cc31b66f5b5d598580ee4b15ae9c8"}],"relatedEducation":[{"id":1363,"name":"Oral Contraception: From Evidence to Practice ","image":"42d0a4f8a46f82c540c4c00afded1b3fc29d0ff0c0c808504d3cc458","imageThumbnail":"4b3f571a5a638bcdc9c3d417204de62c4244bd5b7e63d21fe20d6a61","type":"zoom-webinar","startDateTime":"2026-09-09T09:30:00.000Z","durationSecs":5400,"associationEducationTypes":["EA","MO","RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1373,"name":"Hormonal Acne Management for General Practice","image":"8980d52fa2537eff660b08b44f79752a006b26b23d223206ddf22a8a","imageThumbnail":"bb0b3a191abc66b9631de005b87931e2765d514fc7d71ae5d2fd8f57","type":"zoom-webinar","startDateTime":"2026-10-08T08:30:00.000Z","durationSecs":5400,"associationEducationTypes":["EA","MO","RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1371,"name":"Fracture risk perception and medication adherence","image":"8a32746a58f9ae41f671a7e9c947bb28f50471654044468665d3c5e7","imageThumbnail":"0563278e7f8893527677202c291cc4fc492c520ca53ccc1b743c91e6","type":"video","startDateTime":null,"durationSecs":454,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1370,"name":"Pharmacological considerations for long-term antiresorptive drug (ARD) therapy ","image":"486aaf82a6cd773abd54f88e7e0df641b671075061b3281e755c87af","imageThumbnail":"bf7fe9ca785b08607ae90187607860a533437433ba322ada091c4858","type":"video","startDateTime":null,"durationSecs":677,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1369,"name":"Medication-Related Osteonecrosis of the Jaw (MRONJ) and Osteoporosis","image":"8c4c071a6aaf8b1a9bcb1fd512eb112139c29ab8a970878215410ac9","imageThumbnail":"c5c976a9d9686a6b4364971a7987bb1e88ebae607f5ffcfb4dc3ea69","type":"video","startDateTime":null,"durationSecs":475,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1367,"name":"Diagnosing osteoporosis and the latest treatment pathways","image":"4086d7dafc37fcd4356cd14c54e79767426d7f838825d6adc9e4684a","imageThumbnail":"e92410f1c9fa8ea1dd05b02c7b9594a42922d0be0c0ec815fee88113","type":"video","startDateTime":null,"durationSecs":855,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}}]}